IL-8/CXCL8 Upregulates 12-Lipoxygenase Expression in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: We previously demonstrated remarkable differences in the expression of IL-8/CXCL8 in aortic tissues and vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR) compared to VSMC from normotensive Wistar-Kyoto rats (WKY). In the present study, we investigated the direct effect of IL-8/CXCL8 on expression of 12-lipoxygenase (LO), a hypertensive modulator, in SHR VSMC. Methods: Cultured aortic VSMC from SHR and WKY were used. Expression of 12-LO mRNA was determined by real-time polymerase chain reaction. Phosphorlyation of ERK1/2 and production of 12-LO and angiotensin II subtype 1 (AT1) receptor were assessed by Western blots. IL-8/CXCL8-stimulated DNA synthesis was determined by measuring incorporation of [3H]-thymidine. And effect of IL-8/CXCL8 on vascular tone was determined by phenylephrine- induced contraction of thoracic aortic rings. Results: Treatment with IL-8/CXCL8 greatly increased 12-LO mRNA expression and protein production compared to treatment with angiotensin II. IL-8/CXCL8 also increased the expression of the AT1 receptor. The increase in 12-LO induced by IL-8/CXCL8 was inhibited by treatment with an AT1 receptor antagonist. The induction of 12-LO mRNA production and the proliferation of SHR VSMC by IL-8/CXCL8 was mediated by the ERK pathway. The proliferation of SHR VSMC and the vascular contraction in the thoracic aortic ring, both of which were induced by IL-8/CXCL8, were inhibited by baicalein, a 12-LO inhibitor. Conclusion: These results suggest that the potential role of IL-8/CXCL8 in hypertensive processes is likely mediated through the 12-LO pathway.
Abstract
Background: We previously demonstrated remarkable differences in the expression of IL-8/CXCL8 in aortic tissues and vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR) compared to VSMC from normotensive Wistar-Kyoto rats (WKY). In the present study, we investigated the direct effect of IL-8/CXCL8 on expression of 12-lipoxygenase (LO), a hypertensive modulator, in SHR VSMC. Methods: Cultured aortic VSMC from SHR and WKY were used. Expression of 12-LO mRNA was determined by real-time polymerase chain reaction. Phosphorlyation of ERK1/2 and production of 12-LO and angiotensin II subtype 1 (AT1) receptor were assessed by Western blots. IL-8/CXCL8-stimulated DNA synthesis was determined by measuring incorporation of [3H]-thymidine. And effect of IL-8/CXCL8 on vascular tone was determined by phenylephrine- induced contraction of thoracic aortic rings. Results: Treatment with IL-8/CXCL8 greatly increased 12-LO mRNA expression and protein production compared to treatment with angiotensin II. IL-8/CXCL8 also increased the expression of the AT1 receptor. The increase in 12-LO induced by IL-8/CXCL8 was inhibited by treatment with an AT1 receptor antagonist. The induction of 12-LO mRNA production and the proliferation of SHR VSMC by IL-8/CXCL8 was mediated by the ERK pathway. The proliferation of SHR VSMC and the vascular contraction in the thoracic aortic ring, both of which were induced by IL-8/CXCL8, were inhibited by baicalein, a 12-LO inhibitor. Conclusion: These results suggest that the potential role of IL-8/CXCL8 in hypertensive processes is likely mediated through the 12-LO pathway.
참고문헌 (24)
- Alexander RW, "Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective", Hypertension, 25, pp.155~161 (1995)
- Capers Q 4th, "Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats", Hypertension, 30, pp.1397~1402 (1997)
- Zhang Y, "Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2", Hypertension, 46, pp.732~737 (2005)
- Rodríguez-Iturbe B, "Oxidative stress, renal infiltration of immune cells and salt-sensitive hypertension: all for one and one for all", Am J Physiol, 286, pp.F606~F616 (2004)
- Dhungana S, "Cytokines and chemokines in idiopathic intracranial hypertension", Headache, 49, pp.282~285 (2009)
- Gerszten RE, "MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions", Nature, 398, pp.718~723 (1999)
- Boekholdt S, "IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women", Arterioscler Thromb Vasc Biol, 24, pp.1503~1508 (2004)
- Kim HY, "Upregulation of IL-8", CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats, 2008, pp.31, 515~523
- Natarajan R, "Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells", Hypertension, 30, pp.873~879 (1997)
- Preston IR, "Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation", Am J Lung Cell Mol Physiol, 290, pp.L367~L374 (2006)
- Merched AJ, "Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators", FASEB J, 22, pp.3595~3606 (2008)
- Reddy MA, "Role of Src tyrosine kinase in the atherogenic effects of the 12", 15-lipoxygenase pathway in vascular smooth muscle cells, 2009, pp.29, 387~393
- Natarajan R, "Elevated glucose angiontensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells", Proc Natl Acad Sci USA, 90, pp.4947~4951 (1993)
- Kim JA, "A leukocyte type 12-lipoxygenase is expressed in human vascular and mononuclear cells: Evidence for upregulation by angiotensin II", Arterioscler Thromb Vasc Biol, 15, pp.942~948 (1995)
- Sasaki M, "Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat", Am J Hypertens, 10, pp.371~378 (1997)
- Yue TL, "Interleukin-8: a mitogen and chemoattractant for vascular smooth muscle cells", Circ Res, 75, pp.1~7 (1994)
- Usui M, "Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats", Circulation, 101, pp.305~310 (2000)
- Wolf G, "Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors", Kidney Int, 91, pp.1986~1995 (2002)
- Siragy HM, "AT1 and AT2 receptors in the kidney: Role of disease and treatment", Am J Kidney Dis, 36, pp.S4~S9 (2000)
- Horiuchi M, "Recent progress in angiotensin II Type 2 receptor research in the cardiovascular system", Hypertension, 33, pp.613~621 (1999)
- Jin XQ, "Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells", Hypertension, 39, pp.1021~1027 (2002)
- Reddy MA, "Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells", Am J Physiol Renal Physiol, 283, pp.F985~F994 (2002)
- Buemi M, "Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in eryth rocytes from subjects with essential hypertension", Curr Med Res Opin, 20, pp.19~24 (2004)
- Ohkawa F, "Effects of inflammatory cytokines on vascular tone", Cardiovasc Res, 30, pp.711~715 (1995)